The Series A funding will enable completion of the development of the company’s unique co-manipulative surgical robotic product and prepare it for a successful commercial launch.
PARIS, FRANCE and SAN FRANCISCO, CA / ACCESSWIRE / June 7, 2022 / Moon Surgical, a pioneer in collaborative robotics, today announced that it has secured $31.3 million in Series A funding. The financing round was led by GT Healthcare Capital & Partners, with participation by Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Cathay Health, and existing investor, Sofinnova Partners, as well as seasoned MedTech leaders including Yann Fleureau, Siddarth Satish, Sacha Loiseau, and Richard Leparmentier.
Moon Surgical will use the funding to expand its team in both France and the United States and accelerate the development of its Maestro Robotic System.
“At Moon Surgical, our ambition is to revolutionize minimally invasive surgery through the power of collaborative and adaptive robotics. Our Maestro System can be used in any laparoscopy, in any operating room,” said Anne Osdoit, CEO of Moon Surgical, and a Partner in Sofinnova Partners’ medtech accelerator, MD Start. “We are excited to work with our new partners at GT Healthcare, Johnson & Johnson, and Cathay Health as we enter the next stage of our company’s evolution.”